Cholecystectomy in humans, prevention of vomiting and postoperative tremor, 5-HT3 antagonist, total intravenous anesthesia. Cholecystitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18 and 70 years; physical status ASA 1 or 2; elective surgery; upper abdominal laparoscopy; general intravenous anesthesia; analysis of the QTc interval on the electrocardiogram
Exclusion criteria
Exclusion criteria: History of hypersensitivity or contraindication to the use of the 5-HT3 antagonist. Intellectual inability to cooperate with evaluation procedures. Pregnant patient. Use of any potentially antiemetic medication within less than 24 hours. Symptom of nausea or vomiting in the last 24 hours. Alcoholics. Drug users.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Control of nausea or vomiting and tremor in the first 24 postoperative hours, with the use of 5- HT3 antagonist during the video-cholecystomy procedure under total intravenous anesthesia.;Effective control of nausea or vomiting and tremor in the first 12 postoperative hours with the use of 5- HT3 antagonist during the video-cholecystomy procedure under total intravenous anesthesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Rhodes Scale, used to assess nausea or vomiting in the postoperative period, in 60 individuals who underwent the procedure of videocolecystomy under total intravenous anesthesia, was applied 12 and 24 hours after the end of surgery. The occurrence of tremor was investigated in the first 24 hours. | — |
Countries
Brazil
Contacts
Universidade Federal de Uberlandia;Universidade Federal de Uberlandia